SCHEMBL4877680

SCHEMBL4877680

COc1ccc(CN2C[C@@H]3C(c4ccc(NC(=O)O)cc4)[C@@H]3C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.53
HIF1A Q16665 1/20 0.51
EPAS1 Q99814 1/20 0.51
KMT2A Q03164 3/20 0.50
POLB P06746 2/20 0.50
HSD17B10 Q99714 1/20 0.50
PKM P14618 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KDM4E B2RXH2 2/20 0.48
PAX8 Q06710 1/20 0.48
MAPT P10636 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
TNF P01375 1/20 0.47
NOD2 Q9HC29 1/20 0.47
NOD1 Q9Y239 1/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12489466 0.85 PAX8 (0.56) ALDH1A1KDM4EPAX8MAPTSMN1; SMN2
SCHEMBL12488083 0.85 PAX8 (0.56) ALDH1A1KDM4EPAX8MAPTSMN1; SMN2
SCHEMBL12488080 0.85 PAX8 (0.56) ALDH1A1KDM4EPAX8MAPTSMN1; SMN2
SCHEMBL12488076 0.85 PAX8 (0.56) ALDH1A1KDM4EPAX8MAPTSMN1; SMN2
SCHEMBL4884973 0.85 LMNA (0.54) FAAHKMT2AHSD17B10ALDH1A1MAPT
SCHEMBL14197151 0.85 LMNA (0.54) FAAHKMT2AHSD17B10ALDH1A1MAPT
SCHEMBL8068944 0.82 SIGMAR1 (0.62) FAAHKMT2AALDH1A1PAX8SMN1; SMN2
SCHEMBL19559108 0.77 SIGMAR1 (0.51) KMT2AKDM4EPAX8SMN1; SMN2SIGMAR1
SCHEMBL29135461 0.75 SAE1 (0.78) HIF1AKMT2APOLBALDH1A1KDM4E
SCHEMBL992202 0.75 RAB9A (0.73) KMT2APOLBALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES OXA1L, CYP51A1, CYP2C19 FAAH 4333/4885HIF1A 2150/4885EPAS1 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.